ArticleScientific reports2022

Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan.

Masashi Fujita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.